Mass spectrometry in high-throughput proteomics: ready for the big time
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Mass spectrometry has evolved and matured to a level where it is able to assess the complexity of the human proteome. We discuss some of the expected challenges ahead and promising strategies for success.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While there have been remarkable advances in quantitative mass spectrometry (Nilsson et al., 2010), it is difficult to match the large dynamic range and comprehensive nature of deep sequencing.”
From Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes (2011) · cites this paper as Nilsson et al., 2010
In the citing paper
“Proper procedures in sample collection, sample preparation, MS experiments and data analysis are all critical to obtain high-quality data for hypothesis-driven or proteome-wide discovery research (Nilsson et al., 2010).”
From Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases (2016) · cites this paper as Nilsson et al., 2010
In the citing paper
“Thus, proteomics is positioned to define the functional roles of proteins in normal and disease-related cellular processes, and to enable hypothesis-driven and discovery research of human diseases (Nilsson et al., 2010).”
From Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases (2016) · cites this paper as Nilsson et al., 2010
In the citing paper
“Again, with regard to large-scale proteome quantification (i.e., 4000+ proteins) across laboratories in >200 measurements, these findings are unprecedented and have evolved to a level where many of the previously described limitations of data acquisition in MS-based proteomics62 are being significantly overcome.”
From Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry (2017) · cites this paper as [62]
In the citing paper
“Mass spectrometry (MS)–based methods continue to be the most widely used methods for high-throughput proteomics research1–4”
From Recent trends of capillary electrophoresis‐mass spectrometry in proteomics research (2019) · cites this paper as [3]
Citations
Cites
Finishing the euchromatic sequence of the human genome
International Human Genome Sequencing Consortium (2004) · Nature · doi:10.1038/nature03001 · Cited by 4,971
Genome-Wide Analysis in Vivo of Translation with Nucleotide Resolution Using Ribosome Profiling
Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. S., & Weissman, J. S. (2009) · Science · doi:10.1126/science.1168978 · Cited by 3,853
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Molecular anatomy of a trafficking organelle
Takamori, S., Holt, M., Stenius, K., Lemke, E. A., Grønborg, M., Riedel, D., Urlaub, H., Schenck, S., Brügger, B., Ringler, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.030 · Cited by 2,373
A vision for the future of genomics research
Collins, F. S., Green, E. D., Guttmacher, A. E., Guyer, M. S., & on behalf of the US National Human Genome Research Institute (2003) · Nature · doi:10.1038/nature01626 · Cited by 1,752
Absolute Quantification of Proteins by LCMSE
Silva, J. C., Gorenstein, M. V., Li, G.-Z., Vissers, J. P. C., & Geromanos, S. J. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500230-mcp200 · Cited by 1,529
Addona, T. A., Abbatiello, S. E., Schilling, B., Skates, S. J., Mani, D. R., Bunk, D. M., Spiegelman, C. H., Zimmerman, L. J., Ham, A.-J. L., Keshishian, H., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1546 · Cited by 1,037
Desiere, F. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj040 · Cited by 910
Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast
de Godoy, L. M. F., Olsen, J. V., Cox, J., Nielsen, M. L., Hubner, N. C., Fröhlich, F., Walther, T. C., & Mann, M. (2008) · Nature · doi:10.1038/nature07341 · Cited by 873
Self-citationKrüger, M., Moser, M., Ussar, S., Thievessen, I., Luber, C. A., Forner, F., Schmidt, S., Zanivan, S., Fässler, R., & Mann, M. (2008) · Cell · doi:10.1016/j.cell.2008.05.033 · Cited by 680
Self-citation
Cited by
Ingolia, N. T., Lareau, L. F., & Weissman, J. S. (2011) · Cell · doi:10.1016/j.cell.2011.10.002 · Cited by 2,187
“Although there have been remarkable advances in quantitative mass spectrometry (Nilsson et al., 2010), it is difficult to match the large dynamic range and comprehensive nature of deep sequencing.”
BackgroundUniversal and Confident Phosphorylation Site Localization Using phosphoRS
Taus, T., Köcher, T., Pichler, P., Paschke, C., Schmidt, A., Henrich, C., & Mechtler, K. (2011) · Journal of Proteome Research · doi:10.1021/pr200611n · Cited by 870
Hydrogen exchange mass spectrometry for studying protein structure and dynamics
Konermann, L., Pan, J., & Liu, Y.-H. (2011) · Chem. Soc. Rev. · doi:10.1039/c0cs00113a · Cited by 838
Unraveling the Mechanism of Electrospray Ionization
Konermann, L., Ahadi, E., Rodriguez, A. D., & Vahidi, S. (2013) · Analytical Chemistry · doi:10.1021/ac302789c · Cited by 735
Systems biology of cisplatin resistance: past, present and future
Galluzzi, L., Vitale, I., Michels, J., Brenner, C., Szabadkai, G., Harel-Bellan, A., Castedo, M., & Kroemer, G. (2014) · Cell Death & Disease · doi:10.1038/cddis.2013.428 · Cited by 782
Quantitative, High-Resolution Proteomics for Data-Driven Systems Biology
Cox, J., & Mann, M. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061308-093216 · Cited by 685
Self-citationMapping intact protein isoforms in discovery mode using top-down proteomics
Tran, J. C., Zamdborg, L., Ahlf, D. R., Lee, J. E., Catherman, A. D., Durbin, K. R., Tipton, J. D., Vellaichamy, A., Kellie, J. F., Li, M., et al. (2011) · Nature · doi:10.1038/nature10575 · Cited by 665
“Together with the careful curation of the Swiss-Prot database 6 , the result is an informatics framework that maps each given protein identification to a single gene (except in rare cases like ubiquitin where multiple genes can produce the identical sequence).”
Collins, B. C., Hunter, C. L., Liu, Y., Schilling, B., Rosenberger, G., Bader, S. L., Chan, D. W., Gibson, B. W., Gingras, A.-C., Held, J. M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00249-5 · Cited by 576
Self-citationUltra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection
Messner, C. B., Demichev, V., Wendisch, D., Michalick, L., White, M., Freiwald, A., Textoris-Taube, K., Vernardis, S. I., Egger, A.-S., Kreidl, M., et al. (2020) · Cell Systems · doi:10.1016/j.cels.2020.05.012 · Cited by 561
“For routine applications, MS-based proteomic methods must combine precision, reproducibility, and robustness with low cost and high throughput, such that results can be routinely compared within and between clinical studies and laboratories (Geyer et al., 2017, 2019; Nilsson et al., 2010; Wright and Van Eyk, 2017).”
BackgroundPaxdb, a database of protein abundance averages across all three domains of life
Wang, M., Weiss, M., Simonovic, M., Haertinger, G., Schrimpf, S. P., Hengartner, M. O., & von Mering, C. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o111.014704 · Cited by 466
Sun, Y. V., & Hu, Y.-J. (2016) · Advances in Genetics · doi:10.1016/bs.adgen.2015.11.004 · Cited by 459
“Proper procedures in sample collection, sample preparation, MS experiments and data analysis are all critical to obtain high-quality data for hypothesis-driven or proteome-wide discovery research (Nilsson et al., 2010).”
BackgroundHigh-throughput proteomics: a methodological mini-review
Cui, M., Cheng, C., & Zhang, L. (2022) · Laboratory Investigation · doi:10.1038/s41374-022-00830-7 · Cited by 370
“Mass spectrometry (MS) has been developed as one of the most essential and popular tools to identify proteins and their isoforms, and quantify posttranslational modi fi cations, either via the fragments directly or the speci fi c proteolytic activity responsible for their formation 13 – 15 .”
BackgroundGatto, L., & Lilley, K. S. (2012) · Bioinformatics · doi:10.1093/bioinformatics/btr645 · Cited by 377
“Proteomics, the analysis of the entire protein complement expressed by a genome, has recently benefited from substantial technological advances (Nilsson et al., 2010).”
Glatter, T., Ludwig, C., Ahrné, E., Aebersold, R., Heck, A. J. R., & Schmidt, A. (2012) · Journal of Proteome Research · doi:10.1021/pr300273g · Cited by 364
Self-citationThe human proteome project: current state and future direction
Legrain, P., Aebersold, R., Archakov, A., Bairoch, A., Bala, K., Beretta, L., Bergeron, J., Borchers, C. H., Corthals, G. L., Costello, C. E., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.009993 · Cited by 352
“We concluded that recent substantial advances in proteomic technologies including quantitative mass spectrometry, protein capture with antibodies, and bioinformatics for global exchange of large primary data sets and databases make the generation of such a human proteome map feasible (2, 3).”
BackgroundSelf-citationVidova, V., & Spacil, Z. (2017) · Analytica Chimica Acta · doi:10.1016/j.aca.2017.01.059 · Cited by 352
“The possible reason may be relatively challenging standardization of quantitative results between laboratories, especially for non-expert users and the initial costs of equipment and training [2,123].”
BackgroundBulked sample analysis in genetics, genomics and crop improvement
Zou, C., Wang, P., & Xu, Y. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12559 · Cited by 323
“With the rapid development in liquid chromatography coupling with tandem MS (LC-MS/MS), large-scale proteome identification and quantification can be achieved (Cooper et al., 2011; Nilsson et al., 2010; Ning et al., 2011).”
MethodYang, S.-M., Lv, S., Zhang, W., & Cui, Y. (2022) · Sensors · doi:10.3390/s22041620 · Cited by 299
Ultra-fast proteomics with Scanning SWATH
Messner, C. B., Demichev, V., Bloomfield, N., Yu, J. S. L., White, M., Kreidl, M., Egger, A.-S., Freiwald, A., Ivosev, G., Wasim, F., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00860-4 · Cited by 308
Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer
Unterleuthner, D., Neuhold, P., Schwarz, K., Janker, L., Neuditschko, B., Nivarthi, H., Crncec, I., Kramer, N., Unger, C., Hengstschläger, M., et al. (2020) · Angiogenesis · doi:10.1007/s10456-019-09688-8 · Cited by 299
Mass spectrometry: come of age for structural and dynamical biology
Benesch, J. L., & Ruotolo, B. T. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.08.002 · Cited by 264
“This simple strategy is analogous to ‘spectrum counting’, a methodology widely used in quantitative proteomics [3].”
BackgroundMethodMultiplexed and data‐independent tandem mass spectrometry for global proteome profiling
Chapman, J. D., Goodlett, D. R., & Masselon, C. D. (2014) · Mass Spectrometry Reviews · doi:10.1002/mas.21400 · Cited by 259
Advances in human proteomics at high scale with the SOMAscan proteomics platform
Gold, L., Walker, J. J., Wilcox, S. K., & Williams, S. (2012) · New Biotechnology · doi:10.1016/j.nbt.2011.11.016 · Cited by 261
Piehowski, P. D., Zhu, Y., Bramer, L. M., Stratton, K. G., Zhao, R., Orton, D. J., Moore, R. J., Yuan, J., Mitchell, H. D., Gao, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13858-z · Cited by 263
Redox Proteomics: Chemical Principles, Methodological Approaches and Biological/Biomedical Promises
Bachi, A., Dalle-Donne, I., & Scaloni, A. (2013) · Chemical Reviews · doi:10.1021/cr300073p · Cited by 251
Zhu, Y., Clair, G., Chrisler, W. B., Shen, Y., Zhao, R., Shukla, A. K., Moore, R. J., Misra, R. S., Pryhuber, G. S., Smith, R. D., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201802843 · Cited by 259
An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome
Bian, Y., Song, C., Cheng, K., Dong, M., Wang, F., Huang, J., Sun, D., Wang, L., Ye, M., & Zou, H. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2013.11.014 · Cited by 251
“[35] Nilsson T, Mann M, Aebersold R, Yates III JR, Bairoch A, Bergeron JJ.”
BackgroundOMICtools: an informative directory for multi-omic data analysis
Henry, V. J., Bandrowski, A. E., Pepin, A.-S., Gonzalez, B. J., & Desfeux, A. (2014) · Database · doi:10.1093/database/bau069 · Cited by 240
Piehowski, P. D., Petyuk, V. A., Orton, D. J., Xie, F., Moore, R. J., Ramirez-Restrepo, M., Engel, A., Lieberman, A. P., Albin, R. L., Camp, D. G., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr301146m · Cited by 228
General Statistical Framework for Quantitative Proteomics by Stable Isotope Labeling
Navarro, P., Trevisan-Herraz, M., Bonzon-Kulichenko, E., Núñez, E., Martínez-Acedo, P., Pérez-Hernández, D., Jorge, I., Mesa, R., Calvo, E., Carrascal, M., et al. (2014) · Journal of Proteome Research · doi:10.1021/pr4006958 · Cited by 217
Drug Metabolite Profiling and Identification by High-resolution Mass Spectrometry
Zhu, M., Zhang, H., & Humphreys, W. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.200055 · Cited by 214
Sajic, T., Liu, Y., & Aebersold, R. (2015) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201400117 · Cited by 210
Self-citationUnderstanding interactions between biomaterials and biological systems using proteomics
Othman, Z., Cillero Pastor, B., van Rijt, S., & Habibovic, P. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.020 · Cited by 202
“clearing, and using high-mass resolution instrumentation to identify low-abundant proteins [36].”
BackgroundMethodInfluentialTan, C. S. H., Bodenmiller, B., Pasculescu, A., Jovanovic, M., Hengartner, M. O., Jørgensen, C., Bader, G. D., Aebersold, R., Pawson, T., & Linding, R. (2009) · Science Signaling · doi:10.1126/scisignal.2000316 · Cited by 197
Self-citationSaka, H. A., Thompson, J. W., Chen, Y., Kumar, Y., Dubois, L. G., Moseley, M. A., & Valdivia, R. H. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07877.x · Cited by 178
“mixtures (Nilsson et al., 2010; Walther and Mann, 2010).”
BackgroundApplications of targeted proteomics in systems biology and translational medicine
Ebhardt, H. A., Root, A., Sander, C., & Aebersold, R. (2015) · PROTEOMICS · doi:10.1002/pmic.201500004 · Cited by 184
Self-citationDeeb, S. J., D'Souza, R. C. J., Cox, J., Schmidt-Supprian, M., & Mann, M. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.015362 · Cited by 173
“[6] amino acids and supplemented with 20% dialyzed fetal bovine serum.”
MethodSelf-citationNeutral particle mass spectrometry with nanomechanical systems
Sage, E., Brenac, A., Alava, T., Morel, R., Dupré, C., Hanay, M. S., Roukes, M. L., Duraffourg, L., Masselon, C., & Hentz, S. (2015) · Nature Communications · doi:10.1038/ncomms7482 · Cited by 164
Human Proteome Project Mass Spectrometry Data Interpretation Guidelines 2.1
Deutsch, E. W., Overall, C. M., Van Eyk, J. E., Baker, M. S., Paik, Y.-K., Weintraub, S. T., Lane, L., Martens, L., Vandenbrouck, Y., Kusebauch, U., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00392 · Cited by 165
Self-citationHilton, G. R., & Benesch, J. L. P. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2011.0823 · Cited by 181
Clough, T., Thaminy, S., Ragg, S., Aebersold, R. H., & Vitek, O. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-s16-s6 · Cited by 157
“In many investigations, specifically in systems biology [8] and in the discovery of biomarkers of disease [9,10], it is necessary and appropriate to summarize all the features into protein-level conclusions.”
BackgroundSelf-citationBruderer, R., Bernhardt, O. M., Gandhi, T., & Reiter, L. (2016) · PROTEOMICS · doi:10.1002/pmic.201500488 · Cited by 149
“Liquid chromatography mass spectrometry (LC-MS) is a powerful and widely used approach to identify and quantify proteins [1].”
BackgroundMass Spectrometry Methods for Studying Structure and Dynamics of Biological Macromolecules
Konermann, L., Vahidi, S., & Sowole, M. A. (2013) · Analytical Chemistry · doi:10.1021/ac4039306 · Cited by 160
Bateman, N. W., Goulding, S. P., Shulman, N., Gadok, A. K., Szumlinski, K. K., MacCoss, M. J., & Wu, C. C. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.026500 · Cited by 139
Finoulst, I., Pinkse, M. W. H., van Dongen, W. D., & Verhaert, P. D. E. M. (2011) · BioMed Research International · doi:10.1155/2011/245291 · Cited by 137
Zaffagnini, M., Fermani, S., Marchand, C. H., Costa, A., Sparla, F., Rouhier, N., Geigenberger, P., Lemaire, S. D., & Trost, P. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7617 · Cited by 138
“F or p er so na l u se o nl y. modifications (PTMs) of protein Cys, in a complex interplay that involves also glutaredoxins (GRXs) and glutathione, besides classical TRXs. Section III witnesses the impressive development of redox proteomic techniques that occurs during the past two decades.”
BackgroundInfluentialMass spectrometric protein maps for biomarker discovery and clinical research
Liu, Y., Hüttenhain, R., Collins, B. C., & Aebersold, R. H. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2013.845089 · Cited by 147
Self-citationThe MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation
Caron, É., Vincent, K., Fortier, M., Laverdure, J., Bramoullé, A., Hardy, M., Voisin, G., Roux, P. P., Lemieux, S., Thibault, P., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.68 · Cited by 136
“Early proteomic studies were conducted with analyzers whose sensitivity (dynamic range) and accuracy were orders of magnitude inferior to that of MS analyzers that are now available (Depontieu et al, 2009; Yates et al, 2009; Nilsson et al, 2010).”
BackgroundThe role of statistical power analysis in quantitative proteomics
Levin, Y. (2011) · PROTEOMICS · doi:10.1002/pmic.201100033 · Cited by 122
Schwämmle, V., León, I. R., & Jensen, O. N. (2013) · Journal of Proteome Research · doi:10.1021/pr400045u · Cited by 121
Modification Site Localization Scoring Integrated into a Search Engine
Baker, P. R., Trinidad, J. C., & Chalkley, R. J. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.008078 · Cited by 132
“Mass spectrometry is the enabling tool for PTM characterization, as it is the only approach that can study thousands of modification sites in a single experiment (3).”
BackgroundOpenMS – A platform for reproducible analysis of mass spectrometry data
Pfeuffer, J., Sachsenberg, T. T., Alka, O., Walzer, M., Fillbrunn, A., Nilse, L., Schilling, O., Reinert, K., & Kohlbacher, O. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.05.016 · Cited by 113
Recent trends of capillary electrophoresis‐mass spectrometry in proteomics research
Gomes, F. P., & Yates, J. R. (2019) · Mass Spectrometry Reviews · doi:10.1002/mas.21599 · Cited by 112
Self-citationAdvances in Proteomic Techniques for Cytokine Analysis: Focus on Melanoma Research
Skalníková, H. K., Čížková, J., Červenka, J., & Vodička, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122697 · Cited by 116
“On the other hand, targeted methods (selected reaction monitoring (SRM) or multiple reaction monitoring (MRM), see below) do not suffer this issue and offer robust and reproducible analysis [76].”
BackgroundMethodDigestion and depletion of abundant proteins improves proteomic coverage
Fonslow, B. R., Stein, B. D., Webb, K. J., Xu, T., Choi, J. H., Park, S. K., & Yates, J. R. (2012) · Nature Methods · doi:10.1038/nmeth.2250 · Cited by 107
Self-citationDiatom Proteomics Reveals Unique Acclimation Strategies to Mitigate Fe Limitation
Nunn, B. L., Faux, J. F., Hippmann, A. A., Maldonado, M. T., Harvey, H. R., Goodlett, D. R., Boyd, P. W., & Strzepek, R. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075653 · Cited by 103
“Proteomics can be used to decipher biochemical pathways [23], [24] and these pathways are likely to be altered depending on whether diatoms encounter quasi-instantaneous or gradual changes in Fe supply.”
BackgroundLarge-scale models of signal propagation in human cells derived from discovery phosphoproteomic data
Terfve, C., Wilkes, E. H., Casado, P., Cutillas, P. R., & Sáez-Rodríguez, J. (2015) · Nature Communications · doi:10.1038/ncomms9033 · Cited by 102
“We reasoned that if this was mostly a result of the undersampling problem 4,10 , then placing the data in its molecular context should be able to reconcile the insights obtained, even if the individual sites that are sampled in each data set are different.”
Bauer, M., Cubizolles, F., Schmidt, A., & Nigg, E. A. (2016) · The EMBO Journal · doi:10.15252/embj.201694462 · Cited by 96
“Comprehensive studies on the proteomes of cells, tissues, or organisms have been reported (e.g. Addona et al , 2009; Nilsson et al , 2010; Beck et al , 2011; Nagaraj et al , 2011; for review, see Bensimon et al , 2012; Kulak et al , 2014; Wilhelm et al , 2014; Hein et al , 2015; Richards et al ,…”
Sandberg, A., Branca, R. M., Lehtiö, J., & Forshed, J. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.10.035 · Cited by 101
Reconstruction of Insulin Signal Flow from Phosphoproteome and Metabolome Data
Yugi, K., Kubota, H., Toyoshima, Y., Noguchi, R., Kawata, K., Komori, Y., Uda, S., Kunida, K., Tomizawa, Y., Funato, Y., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.021 · Cited by 103
Xuan, Y., Bateman, N. W., Gallien, S., Götze, S., Zhou, Y., Navarro, P., Hu, M., Parikh, N., Hood, B. L., Conrads, K. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18904-9 · Cited by 92
Mass spectrometry‐based proteomics: The road to lung cancer biomarker discovery
Indovina, P., Marcelli, E., Pentimalli, F., Tanganelli, P., Tarro, G., & Giordano, A. (2012) · Mass Spectrometry Reviews · doi:10.1002/mas.21355 · Cited by 88
Using R and Bioconductor for proteomics data analysis
Gatto, L., & Christoforou, A. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.04.032 · Cited by 92
“Proteomics is evolving at a rapid pace [1] and updates in technologies and instruments 2 applied to the study of bio-molecules, such as proteins or metabolites, require proper com3 putational infrastructure [2].”
BackgroundPérez‐Riverol, Y., Wang, R., Hermjakob, H., Müller, M., Vesada, V., & Vizcaíno, J. A. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.02.032 · Cited by 91
“Mass spectrometry (MS)-based proteomics has become an increasingly prominent fi eld in the last decade, allowing the identi fi cation, quanti fi cation and characterization of peptides and proteins in biological samples [1,2].”
BackgroundZhou, W., Capello, M., Fredolini, C., Racanicchi, L., Piemonti, L., Liotta, L. A., Novelli, F., & Petricoin, E. F. (2011) · Journal of Proteome Research · doi:10.1021/pr2009274 · Cited by 86
Systematic Errors in Peptide and Protein Identification and Quantification by Modified Peptides
Bogdanow, B., Zauber, H., & Selbach, M. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.055103 · Cited by 83
“Shotgun proteomics is stepping up to explain the diversity and complexity of the entire human proteome (1); a development that comes with more and more extensive data sets.”
BackgroundInfluentialPeptide Identification by Tandem Mass Spectrometry with Alternate Fragmentation Modes
Guthals, A., & Bandeira, N. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r112.018556 · Cited by 81
“Technological and computational developments continue to expand the fundamental role of tandem mass spectrometry(1) (MS(2)) in high throughput proteomics (1).”
BackgroundVowinckel, J., Zelezniak, A., Kibler, A., Bruderer, R., Muelleder, M., Reiter, L., & Ralser, M. (2016) · doi:10.1101/073478 · Cited by 81
Mass spectrometry as a tool to advance polymer science
Bruycker, K. D., Welle, A., Hirth, S., Blanksby, S. J., & Barner‐Kowollik, C. (2020) · Nature Reviews Chemistry · doi:10.1038/s41570-020-0168-1 · Cited by 83
Chen, Q., Yan, G., Gao, M., & Zhang, X. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00808 · Cited by 80
Vowinckel, J., Zelezniak, A., Kibler, A., Bruderer, R., Mülleder, M., Reiter, L., & Ralser, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-22610-4 · Cited by 81
“While narrow peaks are generally desirable in chromatography, in proteomics they amplify the problem of undersampling, a situation that emerges when more peptides elute at any unit in time than the mass spectrometer can process 24 .”
Trevisán-Herraz, M., Bagwan, N., Garcia-Marques, F. J., Rodríguez, J. M., Jorge, I., Ezkurdia, I., Bonzón‐Kulichenko, E., & Vázquez, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty815 · Cited by 76
Proteomics in Drug Development: The Dawn of a New Era?
Frantzi, M., Latosińska, A., & Mischak, H. (2019) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201800087 · Cited by 79
Applications and Developments in Targeted Proteomics: From SRM to DIA/SWATH
Aebersold, R. H., Bensimon, A., Collins, B. C., Ludwig, C., & Sabidó, E. (2016) · PROTEOMICS · doi:10.1002/pmic.201600203 · Cited by 77
“We speculate that the bright line that has separated targeted proteomics from discovery proteomics will begin to fade leaving only a broad quantitative proteomics method for life science research that is robust, reproducible, and comprehensive [13].”
BackgroundSelf-citationComputational Mass Spectrometry–Based Proteomics
Käll, L., & Vitek, O. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002277 · Cited by 82
“served by mass spectrometry [90].”
Tu, C., Mammen, M. J., Li, J., Shen, X., Jiang, X.-S., Hu, Q., Wang, J., Sethi, S., & Qu, J. (2013) · Journal of Proteome Research · doi:10.1021/pr4007602 · Cited by 68
“Furthermore, the ion-current-based method was chosen over spectral counting due to its potential for higher sensitivity of detecting altered proteins and superior accuracy when conducted in a well- controlled manner (20-22).”
Mermelekas, G., Vlahou, A., & Zoidakis, J. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1093937 · Cited by 73
“Even though the nature of the samples determines the level of sensitivity [20], strategies for absolute quantification of proteins have been recently developed in a relatively sample-independent manner, such as SRM/MRM.”
BackgroundMicroRNAs: master regulators of drug resistance, stemness, and metastasis
Raza, U., Zhang, J. D., & Şahin, Ö. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1129-2 · Cited by 73
Precision Oncology Decision Support: Current Approaches and Strategies for the Future
Kurnit, K. C., Dumbrava, E. E. I., Litzenburger, B. C., Khotskaya, Y. B., Johnson, A. M., Yap, T. A., Rodon, J. A., Zeng, J., Shufean, M. A., Bailey, A. M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2494 · Cited by 74
The proteomic future: where mass spectrometry should be taking us
Thelen, J. J., & Miernyk, J. A. (2012) · Biochemical Journal · doi:10.1042/bj20110363 · Cited by 73
A proteomics view of the molecular mechanisms and biomarkers of glaucomatous neurodegeneration
Tezel, G. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.01.004 · Cited by 68
“Compared to earlier protein identification techniques, mass spectrometry-based analysis offers an unbiased technique to handle complex protein mixtures with higher sensitivity (Domon and Aebersold, 2006; Kocher and Superti-Furga, 2007; Nilsson et al., 2010).”
BackgroundHembrough, T., Thyparambil, S. P., Liao, W., Darfler, M. M., Abdo, J., Bengali, K. M., Taylor, P. P., Tong, J., Lara-Guerra, H., Waddell, T. K., et al. (2012) · Clinical Proteomics · doi:10.1186/1559-0275-9-5 · Cited by 67
Microfluidic-Mass Spectrometry Interfaces for Translational Proteomics
Pedde, R. D., Li, H., Borchers, C. H., & Akbari, M. (2017) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.06.006 · Cited by 68
“As pointed out by Nilsson and colleagues, this results in a division of labour between biologists and clinicians (who generate and store the samples) and mass spectrometrists (who typically process samples, operate MS equipment, and evaluate the resulting data, which can compromise data quality due to a lack of accoun…”
BackgroundInfluentialMultiscale Integration of -Omic, Imaging, and Clinical Data in Biomedical Informatics
Phan, J. H., Quo, C. F., Cheng, C., & Wang, M. D. (2012) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2012.2212427 · Cited by 71
“analysis because of biochemical factors, technologies such as mass spectrometry [22], [23] and protein microarrays [24],”
MethodZhou, F., Sikorski, T. W., Ficarro, S. B., Webber, J. T., & Marto, J. A. (2011) · Analytical Chemistry · doi:10.1021/ac200639v · Cited by 64
Hembrough, T., Thyparambil, S. P., Liao, W.-L., Darfler, M. M., Abdo, J., Bengali, K. M., Hewitt, S. M., Bender, R. A., Krizman, D. B., & Burrows, J. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.03.002 · Cited by 64
The Human Immunopeptidome Project, a Suggestion for yet another Postgenome Next Big Thing
Admon, A., & Bassani‐Sternberg, M. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o111.011833 · Cited by 66
“Following the completion of the Human Genome Project (1, 2) and the recent advances in molecular immunology and mass spectrometry (3), we believe that the time is ripe for launching yet another postgenome Grand Challenge, namely the Human Immunopeptidome Project.”
BackgroundAdvancements in mass spectrometry-based glycoproteomics and glycomics
Lu, H., Zhang, Y., & Yang, P. (2016) · National Science Review · doi:10.1093/nsr/nww019 · Cited by 66
Capillary zone electrophoresis-mass spectrometry for bottom-up proteomics
Zhang, Z., Qu, Y., & Dovichi, N. J. (2018) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.08.008 · Cited by 61
Evolution of Mass Spectrometry Instruments and Techniques for Blood Proteomics
Zhao, Y. C., Xue, Q., Wang, M., Meng, B., Jiang, Y., Zhai, R., Zhang, Y., Dai, X., & Fang, X. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00102 · Cited by 62
Scheltema, R. A., & Mann, M. (2012) · Journal of Proteome Research · doi:10.1021/pr201219e · Cited by 61
Self-citationAndjelković, U., & Josić, D. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.04.008 · Cited by 62
Biobank resources for future patient care: developments, principles and concepts
Végvári, Á., Welinder, C., Lindberg, H., Fehniger, T. E., & Marko‐Varga, G. (2011) · Journal of Clinical Bioinformatics · doi:10.1186/2043-9113-1-24 · Cited by 62
“So far 10 global chromosomal consortia has been initiated with the objective to sequence all proteins of a given chromosome, coded by the genome [13-15].”
BackgroundInstant spectral assignment for advanced decision tree-driven mass spectrometry
Bailey, D. J., Rose, C. M., McAlister, G. C., Brumbaugh, J., Yu, P., Wenger, C. D., Westphall, M. S., Thomson, J. A., & Coon, J. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205292109 · Cited by 57
MSProGene: integrative proteogenomics beyond six-frames and single nucleotide polymorphisms
Zickmann, F., & Renard, B. Y. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv236 · Cited by 58
“henselae, a pathogenic bacterium that causes infections such as the cat scratch disease (Omasits et al., 2013). Tandem mass spectra and RNA-Seq reads originate from a study by Omasits et al. (2013) (GEO Series accession number: GSE44564).”
BackgroundAnsari, D., Aronsson, L., Sasor, A., Welinder, C., Rezeli, M., Marko‐Varga, G., & Andersson, R. E. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-87 · Cited by 57
“In clinical protein science, new and future complementary technologies, like quantitative mass spectrometry including protein shotgun sequencing has been instrumental in these achievements [38-40].”
BackgroundProteomics and phosphoproteomics in precision medicine: applications and challenges
Giudice, G., & Petsalaki, E. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx141 · Cited by 59
“However, these data sets have not been extensively used in the precision medicine field because of the time required to run samples, complexity and dynamic range of proteomics samples, lack of reproducibility among laboratories, differences between quantification methods and other confounding factors [19, 20].”
Holzinger, E. R., & Ritchie, M. D. (2012) · Pharmacogenomics · doi:10.2217/pgs.11.145 · Cited by 57
Container-based bioinformatics with Pachyderm
Novella, J. A., Khoonsari, P. E., Herman, S., Whitenack, D., Capuccini, M., Burman, J., Kultima, K., & Spjuth, O. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty699 · Cited by 55
Formation of Gaseous Proteins via the Ion Evaporation Model (IEM) in Electrospray Mass Spectrometry
Aliyari, E., & Konermann, L. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c02290 · Cited by 60
Metadata
- Authors
- Nilsson, T., Mann, M., Aebersold, R., Yates, J. R., Bairoch, A., & Bergeron, J. J. M.
- Affiliations
- Research Institute of the McGill University Health Centre (CA)
- Max Planck Society (DE)
- University of Zurich (CH)
- Scripps Research Institute (US)
- University of Geneva (CH)
- Corresponding author
- Nilsson, Tommy
- Bergeron, John J M
- Venue
- Nature Methods
- Published
- 2010-09
- Volume
- 7
- Issue
- 9
- Pages
- 681-685
- ISSN
- 1548-7091 (ISSN-L)
- 1548-7105
- OpenAlex
- W1975721281
- Cited by
- 470
- References
- 44
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 13 · 2023: 16 · 2022: 10 · 2021: 20 · 2020: 19 · 2019: 26 · 2018: 31 · 2017: 28 · 2016: 38 · 2015: 38 · 2014: 40 · 2013: 53 · 2012: 64
- FWCI
- 25.70
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by
- www.springer.com/tdm (tdm)
- Locations
- Nature Methods (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Keywords
- mass spectrometry, high-throughput proteomics, human proteome, proteome complexity
- MeSH terms
- Humans, Quality Control, Sensitivity and Specificity, Mass Spectrometry, Reproducibility of Results, Proteome, Databases, Protein, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.